Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
seizures
Biotech
Stoke's shares up 90% as epilepsy drug cuts convulsive seizures
Investors are stocking up on Stoke, sending the biotech’s shares flying 90% premarket on the back of positive phase 1/2a data for a seizure medicine.
Annalee Armstrong
,
James Waldron
Mar 26, 2024 9:09am
Neurona knocks out $120M raise a year after layoffs
Feb 8, 2024 8:00am
Gene therapy curbs hard-to-treat form of epilepsy in mice
Dec 15, 2023 6:00am
Empatica plots study to develop seizure prediction algorithm
Nov 30, 2023 1:22pm
Ceribell's EEG monitor lands FDA OK for spotting hidden seizures
Aug 3, 2023 12:07pm
PTC suffers 2nd vatiquinone failure in quick succession
Jun 30, 2023 6:25am